Evidence map›Paper›PMID 33585556›Full record

ArticleFrontiers in molecular biosciences2020

Baicalin Induces Apoptosis and Suppresses the Cell Cycle Progression of Lung Cancer Cells Through Downregulating Akt/mTOR Signaling Pathway.

Xinbing Sui, Xuemeng Han, Peng Chen, Qibiao Wu, Jiao Feng, Ting Duan, Xiaying Chen, Ting Pan, Lili Yan, Ting Jin and 12 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in molecular biosciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Observational
  3. Review
  4. Advancement ofChinese herbal medicines · 2026
    Review
  5. Review
  6. Review
  7. Review
  8. Bioactive Flavonoids fromDrug design, development and therapy · 2026
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Baicalin and lung diseases.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 2 countries.

Xinbing SuiSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Xuemeng HanDepartment of Medical Oncology, School of Medicine, The Affiliated Hospital of Hangzhou Normal University, College of Pharmacy, Hangzhou Normal University, Hangzhou, China.
Peng ChenDepartment of Medical Oncology, School of Medicine, The Affiliated Hospital of Hangzhou Normal University, College of Pharmacy, Hangzhou Normal University, Hangzhou, China.
Qibiao WuState Key Laboratory of Quality Research in Chinese Medicines, Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, China.
Jiao FengDepartment of Medical Oncology, School of Medicine, The Affiliated Hospital of Hangzhou Normal University, College of Pharmacy, Hangzhou Normal University, Hangzhou, China.
Ting DuanDepartment of Medical Oncology, School of Medicine, The Affiliated Hospital of Hangzhou Normal University, College of Pharmacy, Hangzhou Normal University, Hangzhou, China.
Xiaying ChenDepartment of Medical Oncology, School of Medicine, The Affiliated Hospital of Hangzhou Normal University, College of Pharmacy, Hangzhou Normal University, Hangzhou, China.
Ting PanDepartment of Medical Oncology, School of Medicine, The Affiliated Hospital of Hangzhou Normal University, College of Pharmacy, Hangzhou Normal University, Hangzhou, China.
Lili YanDepartment of Medical Oncology, School of Medicine, The Affiliated Hospital of Hangzhou Normal University, College of Pharmacy, Hangzhou Normal University, Hangzhou, China.
Ting JinDepartment of Medical Oncology, School of Medicine, The Affiliated Hospital of Hangzhou Normal University, College of Pharmacy, Hangzhou Normal University, Hangzhou, China.
Yu XiangDepartment of Medical Oncology, School of Medicine, The Affiliated Hospital of Hangzhou Normal University, College of Pharmacy, Hangzhou Normal University, Hangzhou, China.
Quan GaoDepartment of Medical Oncology, School of Medicine, The Affiliated Hospital of Hangzhou Normal University, College of Pharmacy, Hangzhou Normal University, Hangzhou, China.
Chengyong WenDepartment of Medical Oncology, School of Medicine, The Affiliated Hospital of Hangzhou Normal University, College of Pharmacy, Hangzhou Normal University, Hangzhou, China.
Weirui MaDepartment of Medical Oncology, School of Medicine, The Affiliated Hospital of Hangzhou Normal University, College of Pharmacy, Hangzhou Normal University, Hangzhou, China.
Wencheng LiuDepartment of Medical Oncology, School of Medicine, The Affiliated Hospital of Hangzhou Normal University, College of Pharmacy, Hangzhou Normal University, Hangzhou, China.
Ruonan ZhangDepartment of Medical Oncology, School of Medicine, The Affiliated Hospital of Hangzhou Normal University, College of Pharmacy, Hangzhou Normal University, Hangzhou, China.
Bi ChenDepartment of Medical Oncology, School of Medicine, The Affiliated Hospital of Hangzhou Normal University, College of Pharmacy, Hangzhou Normal University, Hangzhou, China.
Mingming ZhangDepartment of Medical Oncology, School of Medicine, The Affiliated Hospital of Hangzhou Normal University, College of Pharmacy, Hangzhou Normal University, Hangzhou, China.
Zuyi YangDepartment of Medical Oncology, School of Medicine, The Affiliated Hospital of Hangzhou Normal University, College of Pharmacy, Hangzhou Normal University, Hangzhou, China.
Na KongDepartment of Medical Oncology, School of Medicine, The Affiliated Hospital of Hangzhou Normal University, College of Pharmacy, Hangzhou Normal University, Hangzhou, China.
Tian XieDepartment of Medical Oncology, School of Medicine, The Affiliated Hospital of Hangzhou Normal University, College of Pharmacy, Hangzhou Normal University, Hangzhou, China.
Xia DingSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Affiliated Hospital of Hangzhou Normal University · CNHangzhou Normal University · CNBeijing University of Chinese Medicine · CNMacau University of Science and Technology · MO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Baicalin, as a natural active ingredient extracted and isolated from the traditional Chinese medicine

Indexed as

Aktapoptosisbaicalincell cyclelung cancer

Identifiers

PMID33585556
PMCPMC7876332
OpenAlexW3127528174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.